CABA - Cabaletta Bio, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Cabaletta Bio, Inc. Common Stock
IPO Date: November 1, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $330.61M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.35 | 4.82%
Avg Daily Range (30 D): $0.12 | 4.40%
Avg Daily Range (90 D): $0.10 | 3.38%
Institutional Daily Volume
Avg Daily Volume: 1.14M
Avg Daily Volume (30 D): 5.02M
Avg Daily Volume (90 D): 4.27M
Trade Size
Avg Trade Size (Sh.): 177
Avg Trade Size (Sh.) (30 D): 302
Avg Trade Size (Sh.) (90 D): 254
Institutional Trades
Total Institutional Trades: 750
Avg Institutional Trade: $1.89M
Avg Institutional Trade (30 D): $1.48M
Avg Institutional Trade (90 D): $1.88M
Avg Institutional Trade Volume: .25M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.34M
Avg Closing Trade (30 D): $1.54M
Avg Closing Trade (90 D): $1.99M
Avg Closing Volume: 325.88K
 
News
Sep 14, 2026 @ 5:00 PM
Lupus Nephritis Market on a Growth Trajectory at a...
Source: Delveinsight
Jun 11, 2025 @ 10:00 AM
Cabaletta Bio Announces New Rese-cel Safety and Ef...
Source: N/A
May 29, 2025 @ 12:00 PM
Cabaletta Bio to Participate in the Jefferies Glob...
Source: N/A
Jan 29, 2025 @ 1:00 PM
Cabaletta Bio to Participate in Guggenheim’...
Source: N/A
Nov 29, 2024 @ 11:46 AM
US Stocks Likely To Open In The Green To End Novem...
Source: Rishabh Mishra
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.51 $-.34 $-.39
Diluted EPS $-1.51 $-.34 $-.39
Revenue $M $M $M
Gross Profit
Net Income / Loss $-181.32M $-51.02M $-43.52M
Operating Income / Loss $-185.52M $-52.02M $-44.3M
Cost of Revenue
Net Cash Flow $79.49M $108.47M $33.65M
PE Ratio